Real-time enrollment status for this higher risk myelodysplastic syndromes clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 3:08 AM UTC
| NCT Number | NCT07672769 |
| Recruiting Status | Recruiting |
| Condition | Higher Risk Myelodysplastic Syndromes |
| Phase | PHASE2 |
| Target Enrollment | 90 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Faron Pharmaceuticals Ltd |
| Last Updated on CT.gov | October 20, 2026 (Yesterday) |
As of October 21, 2026: Clinical trial NCT07672769 is currently recruiting participants. This phase2 study for higher risk myelodysplastic syndromes is actively seeking new participants at 9 locations across the United States. The study is sponsored by Faron Pharmaceuticals Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07672769 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07672769 was last updated Yesterday (October 20, 2026). HelloStudys verifies this status automatically.